Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

130.59 +1.33 (+1.03%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

50 51 Next >

Intuitive Surgical Stock is Both a Legacy and Next-Gen Play

November 01, 2022

It’s hard to believe that the da Vinci Surgical System developed by Intuitive Surgical (NASDAQ: ISRG) is turning 22 years old since its U.S. Food and Drug

Via MarketBeat

Topics Economy

NYSE: ABT Investor Notice: Deadline on October 31, 2022 in Lawsuit Against Abbott Laboratories ↗

October 31, 2022

San Diego, CA -- (SBWIRE) -- 10/31/2022 -- The Shareholders Foundation announced that a deadline is coming up on October 31, 2022 in the lawsuit filed for certain investors of Abbott Laboratories...

Via SBWire

Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Abbott Laboratories (ABT) Investors of Class Action and to Actively Participate

October 31, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Is This Dividend King a Buy Near Its 52-Week Low? ↗

October 28, 2022

Shares of this medical device and diagnostics stock have slumped in 2022.

Via The Motley Fool

Stocks That Hit 52-Week Lows On Thursday ↗

October 20, 2022

Thursday saw 177 companies set new 52-week lows.

Via Benzinga

Why Abbott Laboratories Stock Is Slumping Today ↗

October 19, 2022

A potential drop-off in COVID-19 testing sales is weighing on the healthcare giant's shares today.

Via The Motley Fool

Abbott Laboratories (ABT) Q3 2022 Earnings Call Transcript ↗

October 19, 2022

ABT earnings call for the period ending September 30, 2022.

Via The Motley Fool

ABT MONDAY DEADLINE NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT

October 29, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

ABBOTT LABORATORIES 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT

October 28, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Looking Into Abbott Laboratories's Recent Short Interest ↗

October 27, 2022

Abbott Laboratories's (NYSE:ABT) short percent of float has fallen 16.33% since its last report. The company recently reported that it has 13.99 million shares sold short, which is 0.82% of all regular...

Via Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Latch, Azure, Abbott, and TuSimple and Encourages Investors to Contact the Firm

October 26, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Abbott Labs Reports Narrower-Than-Expected Quarterly Declines, And Shares Topple ↗

October 19, 2022

The company's third-quarter results came in well ahead of expectations.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022 ↗

October 26, 2022

Upgrades

Via Benzinga

ABT FINAL DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT

October 24, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Is Abbott Laboratories Still a Good Dividend Stock to Buy? ↗

October 22, 2022

Third-quarter results were less than encouraging on the surface, but what do they say about the road ahead for Abbott Laboratories?

Via The Motley Fool

Infant Formula Fiasco Weighs On Abbott's Q3 Earnings, Still It Raised FY22 EPS Guidance ↗

October 19, 2022

Via Benzinga

10 Dividend Kings That May Last Centuries ↗

October 22, 2022

The following 10 Dividend Kings have increased their dividends for at least 50 consecutive years, and stand a good chance of increasing their dividends for another 50 years.

Via Talk Markets

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Humanigen, Latch, Azure, and Abbott and Encourages Investors to Contact the Firm

October 21, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Amazon To $175? Plus JP Morgan Cuts Price Target On Meta Platforms ↗

October 21, 2022

JP Morgan cut the price target on Amazon.com, Inc. (NASDAQ: AMZN) from $185 to $175. Amazon shares gained 2.2% to trade at $117.82 on Friday.

Via Benzinga

Market Rallies, Hits Resistance As Treasury Yields Soar; Tesla, Netflix Are Big Movers: Weekly Review ↗

October 21, 2022

Tesla hit lows on earnings while Netflix jumped.

Via Investor's Business Daily

Want Passive Income? 3 Dividend Kings to Buy Right Now ↗

October 21, 2022

These companies have what it takes to offer earnings growth over time.

Via The Motley Fool

Bonds And Stocks Slide While Stock Earnings Split ↗

October 20, 2022

The big headline of today was bonds including TLT and IEF extending their downward slide to fresh new lows of 2022.

Via Talk Markets

Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade ↗

October 20, 2022

When saving for retirement, it's important to think beyond near-term market troubles.

Via The Motley Fool

3 Stocks Set to Soar From 52-Week Lows ↗

October 19, 2022

Calling a market bottom is nearly impossible and it isn't likely near but these stocks to buy should be shielded from further declines.

Via InvestorPlace

ABT INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT

October 19, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday ↗

October 20, 2022

Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 19, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session ↗

October 19, 2022

Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.

Via Benzinga

Abbott Laboratories, M&T Bank And Some Other Big Stocks Moving Lower On Wednesday ↗

October 19, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19 ↗

October 19, 2022

Reuters US Lawmakers Plan Hearing On Kroger, Albertsons' $25B Merger

Via Benzinga

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Abbott Laboratories (NY:ABT)

All News about Abbott Laboratories

Starting at $3.75/week.

Subscribe Today